U S Physical Therapy (USPH) EBITDA (2010 - 2026)

U S Physical Therapy has disclosed EBITDA across 17 years of filings, most recently posting $12.5 million for Q1 2026.

• EBITDA for Q1 2026 came in at $12.5 million, down 36.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.5 million (up 17.44% YoY), and the FY2025 annual result was $86.7 million, up 37.6% from the prior year.
• EBITDA came in at $12.5 million for Q1 2026 at U S Physical Therapy, down from $16.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $25.3 million in Q3 2025 to a low of -$40.7 million in Q4 2022.
• The 5-year median for EBITDA is $15.9 million (2023), against an average of $13.1 million.
• Across the five-year window, EBITDA plunged 347.19% in 2022 and soared 908.68% in 2024, its largest moves.
• U S Physical Therapy's EBITDA stood at -$40.7 million in 2022, then soared by 94.03% to -$2.4 million in 2023, then jumped by 908.68% to $19.7 million in 2024, then slipped by 14.68% to $16.8 million in 2025, then dropped by 25.56% to $12.5 million in 2026.
• The last three EBITDA figures came in at $12.5 million (Q1 2026), $16.8 million (Q4 2025), and $25.3 million (Q3 2025), per Business Quant data.